Fingerprint
Dive into the research topics of 'Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis
Naveen Pemmaraju*, Claire Harrison, Vikas Gupta, Srdan Verstovsek, Bart Scott, Stephen T. Oh, Francesca Palandri, Haifa Kathrin Al‐Ali, Marta Sobas, Mary Frances McMullin, Ruben Mesa, Sarah Buckley, Karisse Roman‐Torres, Alessandro Vannucchi, Abdulraheem Yacoub
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
97
Downloads
(Pure)